Doug Niven PhD
Doug Niven has 20+ years of experience in the research, health and life science sectors.
​
-
He has worked extensively with both big pharma and biotechs across the product lifecycle, as well as med tech companies and financial investors
​
-
He has supported the development and commercialisation of over 20 different drugs, covering a broad range of therapeutic areas and modalities at global, regional and country levels
​
Experience and highlights
-
Supporting companies and senior leaders overcome challenges to integrated drug development, through a market-back, non-siloed, 360° approach
​
-
Leading business development and strategic alliances with large pharma and biotechs
-
Leadership and collaboration: direct and matrix leadership across different functions
-
Experience working in professional consultancy and CRO-CCO organisations, including strategic market analysis and market access
​
Highlights:
-
Asset Lead: enabling biotechs to achieve critical development and commercial milestones
-
Director of Strategic Consulting: supporting large and small pharma clients to optimise commercial strategy and execution, due diligence exercises and lifecycle management excellence
​
-
Disease area experience: inflammation and immunology, neurology, rare diseases, oncology, behavioral/mental health, ophthalmology, respiratory, cardiovascular
​
-
Treatment modality experience: small molecules, biologics, cell therapies, digital therapeutics, and medical devices